02/16/2022 | Geoffrey Potjewyd
The leadership team of ARVO give us an insight into how the organization has grown in challenging times
02/10/2022 | Aleksandra Jones
How has glaucoma care and management changed since the start of 2020?
02/07/2022 | Sponsored by PolyPhotonix
PolyPhotonix names Prevail Partners as its lead US investor whose affiliate will lead Noctura 400 FDA clinical trials
02/07/2022 | Aleksandra Jones
On the second anniversary of Li Wenliang's death, we remember the brave novel coronavirus whistleblower
01/21/2022 | Aleksandra Jones
During a live roundtable, esteemed ocular surface experts discussed steps practices can take to effectively manage patients’ dry eye disease
01/06/2022 | Wei Yan Ng, Daniel Shu Wei Ting
Improving artificial intelligence development using blockchain – where digital health technologies converge
12/23/2021
Philip Rosenfeld, an inspiration to the world of retina, shares his life story and his views in an interview with Omer Trivizki
12/22/2021 | Aleksandra Jones
Gerd U. Auffarth talks about his experiences with the ESCRS Congress, milestones in the cataract and refractive field, and life during the pandemic
12/06/2021 | Sponsored by PolyPhotonix
Noctura 400 from PolyPhotonix offers a revolutionary, home-based non-invasive diabetic retinopathy treatment that reduces oxygen demand in the retina
11/02/2021 | Aleksandra Jones
Sitting Down With… Mariya Moosajee, Professor of Molecular Ophthalmology at University College London Institute of Ophthalmology
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
One Eye on the Clock
(Real-World) Knowledge Is Power
VR Visions
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: